Milatuzumab-Sn-38 Conjugates for the Treatment of CD74+ Cancers

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-1170
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search